jadenu

Generic: deferasirox

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name jadenu
Generic Name deferasirox
Labeler novartis pharmaceuticals corporation
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

deferasirox 360 mg/1

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-0656
Product ID 0078-0656_028e6158-3b78-41dd-99a8-6acb582f7245
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA206910
Listing Expiration 2026-12-31
Marketing Start 2015-03-30

Pharmacologic Class

Established (EPC)
iron chelator [epc]
Mechanism of Action
iron chelating activity [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 1a2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00780656
Hyphenated Format 0078-0656

Supplemental Identifiers

RxCUI
1607784 1607790 1607792 1607794 1607796 1607798 1923822 1923825 1923826 1923827 1923828 1923829
UNII
V8G4MOF2V9
NUI
N0000000144 N0000175522 N0000185506 N0000187062 N0000182138

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name jadenu (source: ndc)
Generic Name deferasirox (source: ndc)
Application Number NDA206910 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 360 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (0078-0656-15)
source: ndc

Packages (1)

Ingredients (1)

deferasirox (360 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "028e6158-3b78-41dd-99a8-6acb582f7245", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["1607784", "1607790", "1607792", "1607794", "1607796", "1607798", "1923822", "1923825", "1923826", "1923827", "1923828", "1923829"], "spl_set_id": ["fee89140-fff1-4443-9f42-24ac004fcda1"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0078-0656-15)", "package_ndc": "0078-0656-15", "marketing_start_date": "20150330"}], "brand_name": "Jadenu", "product_id": "0078-0656_028e6158-3b78-41dd-99a8-6acb582f7245", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "0078-0656", "generic_name": "deferasirox", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Jadenu", "active_ingredients": [{"name": "DEFERASIROX", "strength": "360 mg/1"}], "application_number": "NDA206910", "marketing_category": "NDA", "marketing_start_date": "20150330", "listing_expiration_date": "20261231"}